Previous studies have clearly indicated that overreliance on liver enzymes is a mistake, as the diagnosis of NAFLD with advanced fibrosis or inflammation is not ruled out by the presence of normal liver enzymes, and the percentage of patients with normal ALT or GGT levels was 53.6% at baseline. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.